Reaction

Catheter Site Haemorrhage reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,428 reports · 80 co-occurring drugs

As of the last recalculation, Catheter Site Haemorrhage appears in 2,428 FAERS reports alongside 80 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 184.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Epoprostenol	253	184.8	188.5
Macitentan	266	36.9	37.0
Treprostinil	423	34.8	34.9
Sildenafil	184	29.4	29.5
Riociguat	95	26.0	26.0
Sildenafil Powder,	101	25.3	25.4
Tadalafil	247	23.4	23.5
Heparin Sodium	36	22.8	22.8
0Xygen	122	22.3	22.4
Oxygen	122	22.3	22.4
Alteplase	35	20.3	20.3
Sildenafil Citrate	267	20.1	20.1
Ado-Trastuzumab Emtansine	17	17.4	17.4
Cefazolin	17	16.1	16.1
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	16	15.6	15.6
Cefazolin Sodium	20	14.3	14.4
Ambrisentan	193	14.3	14.3
Norepinephrine Bitartrate	22	13.2	13.2
Bosentan	74	12.9	13.0
Norepinephrine	14	11.3	11.3
Sodium Chloride	95	10.7	10.7
Fondaparinux Sodium	10	10.6	10.6
Sodium Chloride Tablet	88	10.6	10.6
Sodium Chloride Tablets	88	10.6	10.6
Bumetanide	32	10.5	10.5
Torsemide	40	10.5	10.5
Warfarin	144	10.3	10.3
Warfarin Sodium	54	10.2	10.2
Pegaspargase	14	9.9	9.9
Acetylcysteine	10	9.1	9.1
Blinatumomab	11	9.1	9.1
Selexipag	26	8.7	8.7
Potassium Chloride, Dextrose Monohydrate	89	8.5	8.5
Potassium Chloride Oral	89	8.5	8.5
Potassium Chloride Extended-Release	89	8.5	8.5
Prasugrel Hydrochloride	10	8.5	8.5
Potassium Chloride	102	8.0	8.0
Midazolam	23	7.9	7.9
Midazolam Hydrochloride	24	7.7	7.7
Ticagrelor	28	7.6	7.6
Bisacodyl	12	7.3	7.3
Bisacodyl Suppositories	11	7.3	7.3
Calcitriol Capsules 0.25 Mcg	17	7.3	7.3
Calcitriol Capsules 0.5 Mcg	17	7.3	7.3
Rocuronium Bromide	10	7.3	7.3
Biscodyl	11	7.3	7.3
Calcitriol	17	7.2	7.2
Ketoprofen	11	7.2	7.2
Enoxaparin Sodium	47	7.1	7.1
Spironolactone	112	7.1	7.1
Sevelamer Carbonate	9	6.7	6.7
Cyclobenzaprine Hydrochloride	7	6.7	6.7
Doxyclycline Hyclate	13	6.6	6.6
Hydroxyzine Hydrochloride	10	6.5	6.5
Hydroxyzine Hydrochloride Oral	10	6.5	6.5
Epoetin Alfa	9	6.5	6.5
Dalteparin Sodium	8	6.5	6.5
Adrenalinum	31	6.5	6.5
Exemestane	16	6.4	6.4
Vincristine Sulfate	21	6.2	6.2
Gentamicin	9	5.9	5.9
Rivaroxaban	130	5.6	5.6
Prochlorperazine Maleate	6	5.6	5.6
Clopidogrel Bisulfate	65	5.6	5.6
Benzonatate	10	5.2	5.2
Pertuzumab	16	5.1	5.1
Cefepime Hydrochloride	9	4.8	4.8
Apixaban	35	4.5	4.5
Dabigatran Etexilate	40	4.5	4.5
Dabigatran Etexilate Mesylate	37	4.4	4.4
Paricalcitol	7	4.3	4.3
Emicizumab	6	4.2	4.2
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	15	4.2	4.2
Sevoflurane	4	4.1	4.1
Teduglutide	6	3.8	3.8
Agalsidase Beta	4	3.7	3.7
Relugolix	10	3.6	3.6
Eculizumab	21	3.3	3.3
Remdesivir	5	3.2	3.2
Cinacalcet Hydrochloride	6	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.